Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00868712 · ClinicalTrials.gov registry record
Warfarin and Coronary Calcification Project
A clinical trial of Coronary Calcification, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT00868712 is a study of Coronary Calcification that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00868712, a study of Coronary Calcification, has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess whether the use of warfarin, a commonly used anticoagulation drug, is associated with increased amounts of coronary artery calcification. Studies in animals and preliminary but small retrospective studies in humans have suggested a possible link to increased tissue calcification with use of this drug. The researchers will investigate this by assessing the amount of calcification seen in the coronary arteries using a specialized computed tomography (CT) scan (electron-beam CT) and assessing to see if the amount is influenced by the amount of time a patient has been taking warfarin. The researchers will exclude patients with known coronary artery disease, chronic kidney disease or hyperparathyroidism.
Conditions Studied
Study Locations (1)
District of Columbia
- Walter Reed Army Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2004-05 |
| Est. Completion | 2010-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00868712
The ClinicalTrials.gov registry entry for NCT00868712 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed Army Medical Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Calcification appearing as the primary indexed condition, and to 0 interventions.
NCT00868712 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00868712 about?
NCT00868712 is a clinical study titled "Warfarin and Coronary Calcification Project". The purpose of the study is to assess whether the use of warfarin, a commonly used anticoagulation drug, is associated with increased amounts of coronary artery calcification. Studies in animals and preliminary but small retrospective studies in humans have suggested a possible link to increased tis...
What is the current status of trial NCT00868712?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2004-05. Estimated completion is 2010-01.
What conditions does trial NCT00868712 study?
This clinical trial studies the following conditions: Coronary Calcification.
Who is sponsoring clinical trial NCT00868712?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00868712 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Calcification
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.